# INSPIRE Diabetes Study: Basal Bolus Insulin as Primary Treatment of Type 2 Diabetes

> **NCT01087567** · PHASE4 · COMPLETED · sponsor: **Ohio University** · enrollment: 23 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Intensive insulin
- **DRUG:** Routine Care

## Key facts

- **NCT ID:** NCT01087567
- **Lead sponsor:** Ohio University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2014-04-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01087567

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01087567, "INSPIRE Diabetes Study: Basal Bolus Insulin as Primary Treatment of Type 2 Diabetes". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01087567. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*